Summary
- Current Price
- RVNC price is unknown, with unknown change on
- Current Price All-Time High
- RVNC price vs all-time high is unknown
- Market Cap
- RVNC market cap is unknown, with unknown 1-year change
- PE Ratio
- RVNC PE ratio is unknown
- Revenue
- RVNC current annual revenue is $234.04M, up +76.55% year-over-year
- Next Earnings
- As of today, the next earnings release for RVNC has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Revance Therapeutics, Inc. |
| Ticker | NASDAQ: RVNC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | revance.com |
| Employees | 597 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| - | ||
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $234M | ||
| Revenue, 1Y Change | +76.55% | |
| -$3.83 | ||
| EPS, 1Y Change | +21.84% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.83 | ||
| EPS Estimate | N/A | -$1.64 |
| EPS Est. Change | N/A | +57.18% |
| $234.04M | ||
| Revenue Estimate | N/A | $264.95M |
| Revenue Est. Change | N/A | +13.21% |
| - | ||
| Price Target | - | $6.60 |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.98 | -$3.83 | +3.77% | |
| -$1.64 | N/A | +57.18% | |
| -$1.01 | N/A | +73.63% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $226.35M | $234.04M | +3.40% | |
| $264.95M | N/A | +13.21% | |
| $333.68M | N/A | +42.57% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +76.55% | ||
| +1,427.18% | ||
| +21.84% | ||
| +21.19% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| - | ||
| N/A | - | |
| SMA 200 vs Price | N/A | - |
| N/A | - | |
| SMA 50 vs Price | N/A | - |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $234.04M | ||
| -$3.83 | ||
| $159.68M | ||
| 68.23% | ||
| -$222.34M | ||
| -95.00% | ||
| -$323.99M | ||
| -138.43% | ||
| -$290.64M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -2.83 | ||
| 3.80 | ||
| 3.29 | ||
| -15.72 | ||
| 3 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$151.60M | ||
| $137.33M | ||
| $478.45M | ||
| $338.87M | ||
| $630.06M | ||
| $89.22M | ||
| $478.43M | ||
| $10.85M | ||
| $13.81M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $456.38M | ||
| $382.01M | ||
| $74.36M | ||
| $292.24M | ||
| $13.69M | ||
| $19.36M | ||
| $300.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$216.58M | ||
| $109.74M | ||
| $136.57M | ||
| $6.89M | ||
| -$223.46M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Needham | → | |
| Barclays | → | |
| Mizuho | → | |
| Needham | ||
| HC Wainwright & Co. | → | |
| Needham | ||
| Barclays | → | |
| Needham | → | |
| William Blair | → | |
| Guggenheim | → |
Analyst sentiment
Institutional ownership
Screeners with RVNC
FAQ
What is the ticker symbol for Revance Therapeutics, Inc.?
The ticker symbol for Revance Therapeutics, Inc. is NASDAQ:RVNC
Does Revance Therapeutics, Inc. pay dividends?
No, Revance Therapeutics, Inc. does not pay dividends
What sector is Revance Therapeutics, Inc. in?
Revance Therapeutics, Inc. is in the Healthcare sector
What industry is Revance Therapeutics, Inc. in?
Revance Therapeutics, Inc. is in the Biotechnology industry
What country is Revance Therapeutics, Inc. based in?
Revance Therapeutics, Inc. is headquartered in United States
When did Revance Therapeutics, Inc. go public?
Revance Therapeutics, Inc. initial public offering (IPO) was on February 6, 2014
Is Revance Therapeutics, Inc. in the S&P 500?
No, Revance Therapeutics, Inc. is not included in the S&P 500 index
Is Revance Therapeutics, Inc. in the NASDAQ 100?
No, Revance Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Revance Therapeutics, Inc. in the Dow Jones?
No, Revance Therapeutics, Inc. is not included in the Dow Jones index
When was Revance Therapeutics, Inc. last earnings report?
Revance Therapeutics, Inc.'s most recent earnings report was on February 28, 2025
When does Revance Therapeutics, Inc. report earnings?
The date for Revance Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- RVNC Official Website www.revance.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1479290/000147929024000128/0001479290-24-000128-index.htm
- RVNC Profile on Yahoo Finance finance.yahoo.com/quote/RVNC
- RVNC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rvnc